Works matching IS 03065251 AND DT 2022 AND VI 88 AND IP 9

Results: 33

Prescribing trend of tapentadol in a Sydney local health district.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3929, doi. 10.1111/bcp.15448

By:

Mirabella, Jennifer;
Ravi, Deepa;
Chiew, Angela L.;
Buckley, Nicholas A.;
Chan, Betty S.

Publication type:

Article

Plasma levels of VEGF‐A and VCAM‐1 as predictors of drug‐induced hypertension in patients treated with VEGF pathway inhibitors.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4171, doi. 10.1111/bcp.15356

By:

Quintanilha, Julia C. F.;
Hammond, Kelli;
Liu, Yingmiao;
Marmorino, Federica;
Borelli, Beatrice;
Cremolini, Chiara;
Nixon, Andrew B.;
Innocenti, Federico

Publication type:

Article

Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4134, doi. 10.1111/bcp.15354

By:

Del Pozzo‐Magaña, Blanca R.;
Rieder, Michael J.;
Garcia‐Bournissen, Facundo;
Lazo‐Langner, Alejandro

Publication type:

Article

Issue highlights.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3927, doi. 10.1111/bcp.15483
Publication type:: Article

Risk factors for vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3977, doi. 10.1111/bcp.15429

By:

Kim, Jee Yun;
Yee, Jeong;
Yoon, Ha Young;
Han, Ji Min;
Gwak, Hye Sun

Publication type:

Article

Pregnancy outcomes following maternal exposure to statins: A systematic review and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3962, doi. 10.1111/bcp.15423

By:

Karadas, Baris;
Uysal, Nusret;
Erol, Hilal;
Acar, Selin;
Koc, Meltem;
Kaya‐Temiz, Tijen;
Koren, Gideon;
Kaplan, Yusuf C.

Publication type:

Article

Pregnancy and neonatal outcomes in women receiving calcineurin inhibitors: A systematic review and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3950, doi. 10.1111/bcp.15414

By:

Akiyama, Shintaro;
Hamdeh, Shadi;
Murakami, Naoka;
Cotter, Thomas G.;
Suzuki, Hideo;
Tsuchiya, Kiichiro

Publication type:

Article

Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4230, doi. 10.1111/bcp.15392

By:

Owen, David R.;
Phillips, Alexandra;
O'Connor, Desmond;
Grey, Gabrielle;
Aimola, Lina;
Nicholas, Richard;
Matthews, Paul M.

Publication type:

Article

Who prescribes quetiapine in Denmark?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4224, doi. 10.1111/bcp.15388

By:

Højlund, Mikkel;
Rasmussen, Lotte;
Olesen, Morten;
Munk‐Olsen, Trine;
Pottegård, Anton

Publication type:

Article

Serum uric acid lowering mediated by glucagon‐like peptide‐1 receptor agonists: Emerging considerations.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4239, doi. 10.1111/bcp.15382

By:

Patoulias, Dimitrios;
Papadopoulos, Christodoulos;
Doumas, Michael

Publication type:

Article

Cardiovascular protection conferred by glucagon‐like peptide‐1 receptor agonists: A role for serum uric acid reduction?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4237, doi. 10.1111/bcp.15381

By:

Najafi, Sara;
Bahrami, Milad;
Butler, Alexandra E.;
Sahebkar, Amirhossein

Publication type:

Article

A review of trial and real‐world data applying elements of a realist approach to identify behavioural mechanisms supporting practitioners to taper opioids.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4019, doi. 10.1111/bcp.15379

By:

Bhattacharya, Debi;
Whiteside, Hattie;
Tang, Emma;
Kantilal, Kumud;
Loke, Yoon;
Atkins, Bethany;
Hill, Caroline

Publication type:

Article

Tapering of the thrombopoietin receptor agonist in paediatric patients with chronic immune thrombocytopenia: Is it possible?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4220, doi. 10.1111/bcp.15378

By:

Solsona, María;
Berrueco, Rubén;
Sebastián, Elena;
Cervera, Áurea;
Sastre, Ana;
Astigarraga, Itziar;
Argilés, Bienvenida;
Dasí, María Ángeles;
Dapena, José Luís;
Monteagudo, Emilio

Publication type:

Article

Parametric population pharmacokinetics of linezolid: A systematic review.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4043, doi. 10.1111/bcp.15368

By:

Qin, Yan;
Zhang, Li‐Li;
Ye, Yan‐Rong;
Chen, Yue‐Ting;
Jiao, Zheng

Publication type:

Article

Angiotensin‐converting enzyme inhibitors and risk of age‐related macular degeneration in individuals with hypertension.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4199, doi. 10.1111/bcp.15366

By:

Subramanian, Anuradhaa;
Han, Diana;
Braithwaite, Tasanee;
Thayakaran, Rasiah;
Zemedikun, Dawit T.;
Gokhale, Krishna M.;
Lee, Wen Hwa;
Coker, Jesse;
Keane, Pearse A.;
Denniston, Alastair K.;
Nirantharakumar, Krishnarajah;
Azoulay, Laurent;
Adderley, Nicola J.

Publication type:

Article

Histamine‐2 (H<sub>2</sub>) antagonists can be safely removed from standard paclitaxel premedication regimens.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4191, doi. 10.1111/bcp.15363

By:

Foreman, Emma;
Polwart, Calum;
Walker, Andrew;
Chambers, Pinkie

Publication type:

Article

Thromboembolic events in Janus kinase inhibitors: A pharmacovigilance study from 2012 to 2021 based on the Food and Drug Administration's Adverse Event Reporting System.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4180, doi. 10.1111/bcp.15361

By:

Dong, Ziwei;
Ye, Xiaofei;
Chen, Chenxin;
Wang, Rui;
Liu, Dongxu;
Xu, Xiao;
Zhou, Xiang;
He, Jia

Publication type:

Article

Ketamine for suicidality: An umbrella review.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3990, doi. 10.1111/bcp.15360

By:

Shamabadi, Ahmad;
Ahmadzade, Ali;
Hasanzadeh, Alireza

Publication type:

Article

Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3947, doi. 10.1111/bcp.15359

By:

D'andrea, Luca;
Montemagni, Marina;
Celenza, Giuseppe;
Iorio, Roberto;
Costagliola, Ciro

Publication type:

Article

Pharmacogenetics may explain part of the interindividual variability of dobutamine pharmacodynamics in neonates.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4155, doi. 10.1111/bcp.15357

By:

Hallik, Maarja;
Soeorg, Hiie;
Kahre, Tiina;
Murumets, Ülle;
Ilmoja, Mari‐Liis;
Kipper, Karin;
Metsvaht, Tuuli

Publication type:

Article

Short‐ and long‐term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4121, doi. 10.1111/bcp.15349

By:

Kvitne, Kine Eide;
Krogstad, Veronica;
Wegler, Christine;
Johnson, Line Kristin;
Kringen, Marianne K.;
Hovd, Markus Herberg;
Hertel, Jens K.;
Heijer, Maria;
Sandbu, Rune;
Skovlund, Eva;
Artursson, Per;
Karlsson, Cecilia;
Andersson, Shalini;
Andersson, Tommy B.;
Hjelmesæth, Jøran;
Åsberg, Anders;
Jansson‐Löfmark, Rasmus;
Christensen, Hege;
Robertsen, Ida

Publication type:

Article

Impact of pre‐emptive rapid testing for glucose‐6‐phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4163, doi. 10.1111/bcp.15353

By:

Ganapathi, Mythily;
Campbell, Peter;
Ofori, Kenneth;
Aggarwal, Vimla;
Francis, Richard O.;
Kratz, Alexander

Publication type:

Article

Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4100, doi. 10.1111/bcp.15348

By:

Hwang, Jun Gi;
Lee, SeungHwan;
Huh, Wan;
Han, Jumi;
Oh, Jaeseong;
Jang, In‐Jin;
Yu, Kyung‐Sang

Publication type:

Article

Management of combined oral antithrombotic therapy by an antithrombotic stewardship program: A prospective study.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4092, doi. 10.1111/bcp.15346

By:

Zhang, Zhu Xian;
Schroeder‐Tanka, Jutta;
Stooker, Wim;
Wissen, Sanne;
Khorsand, Nakisa

Publication type:

Article

Fixed dosing of kukoamine B in sepsis patients: Results from population pharmacokinetic modelling and simulation.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4111, doi. 10.1111/bcp.15342

By:

Wang, Huanhuan;
Wang, Teng;
Hu, Xiaoyun;
Deng, Chenhui;
Jiang, Ji;
Qin, Hanyu;
Dong, Kai;
Chen, Shuai;
Jin, Chunyan;
Zhao, Qian;
Du, Bin;
Hu, Pei

Publication type:

Article

Similarity and consistency assessment of three major online drug–drug interaction resources.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4067, doi. 10.1111/bcp.15341

By:

Kontsioti, Elpida;
Maskell, Simon;
Bensalem, Amina;
Dutta, Bhaskar;
Pirmohamed, Munir

Publication type:

Article

Population pharmacokinetics and exposure–response of anti‐programmed cell death protein‐1 monoclonal antibody dostarlimab in advanced solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4142, doi. 10.1111/bcp.15339

By:

Melhem, Murad;
Hanze, Eva;
Lu, Sharon;
Alskär, Oskar;
Visser, Sandra;
Gandhi, Yash

Publication type:

Article

Efficacy of pharmacological interventions in COVID‐19: A network meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4080, doi. 10.1111/bcp.15338

By:

Selvarajan, Sandhiya;
Anandaradje, Annuja;
Shivabasappa, Santhosh;
Melepurakkal Sadanandan, Deepthy;
Nair, N. Sreekumaran;
George, Melvin

Publication type:

Article

Pharmacogenomics: Relevance and opportunities for clinical pharmacology.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3943, doi. 10.1111/bcp.15329

By:

Turner, Richard M.;
Magavern, Emma F.;
Pirmohamed, Munir

Publication type:

Article

Gaps and opportunities in sustainable medicines use in resource limited settings: A situational analysis of Uganda.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3936, doi. 10.1111/bcp.15324

By:

Kamba, Pakoyo F.;
Nambatya, Winnie;
Aguma, Herbert B.;
Charani, Esmita;
Rajab, Kalidi

Publication type:

Article

Pseudotumour cerebri due to phenytoin in a child.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4217, doi. 10.1111/bcp.15306

By:

Sasidharan Pillai, Sabitha;
Riyaz, Arakkal;
Krishnan, Chakkiyar;
Gireesh, Sankaran Nair

Publication type:

Article

Tranexamic acid‐associated fatal status epilepticus in a paediatric non‐cardiac surgery: A case report and literature review.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4211, doi. 10.1111/bcp.15296

By:

Aboul‐Fotouh, Sawsan;
Habib, Mohamed Z.;
Magdy, Sondos M.;
Hassan, Bahaa El‐din Ewees

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 3925, doi. 10.1111/bcp.14908
Publication type:: Article